Calf circumference measurement as a screening tool for sarcopenia in women with rheumatoid arthritis: a pilot study

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background: Secondary sarcopenia (SP) in rheumatoid arthritis (RA) is not diagnosed due to the complexity of body composition analysis and low information content of muscle strength determination due to joint syndrome. It is necessary to search for available methods for screening low muscle mass.

Objective: Determination of the sensitivity and specificity of calf circumference measurement as a surrogate method for assessing muscle mass in comparison with the «gold standard» – dual-energy X-ray absorptiometry (DXA) in women with RA.

Materials and methods: 201 women with confirmed RA who signed informed consent were examined. Clinical and laboratory examination was performed, including calf circumference measurement and determination of body composition with calculation of appendicular muscle index (AMI) using DXA.

Results: The mean age of the examined women was 59.3±9.0 years. Low AMI was detected in 18.4% of patients. Calf circumference positively correlated with AMI (r=0.52, p<0.001), regardless of the presence of obesity. ROC analysis revealed the value of calf circumference (33.8 cm) with the optimal ratio of sensitivity (73.0%) and specificity (76.2%) for detecting low muscle mass. The area under the curve was 0.789 (95% confidence interval 0.726–0.844, p<0.001).

Conclusion: Calf circumference values are not sensitive enough for screening low muscle mass. It is necessary to search for additional factors to increase the sensitivity of the method without significantly reducing specificity.

Full Text

Restricted Access

About the authors

Olga V. Dobrovolskaya

V.A. Nasonova Research Institute of Rheumatology

Author for correspondence.
Email: olgavdobr@mail.ru
ORCID iD: 0000-0002-2809-0197

Cand. Sci. (Med.), Researcher, Osteoporosis Laboratory

Russian Federation, Moscow

Maria V. Kozyreva

V.A. Nasonova Research Institute of Rheumatology

Email: doginya@yandex.ru
ORCID iD: 0000-0003-0560-3495

Junior Researcher, Osteoporosis Laboratory

Russian Federation, Moscow

Nikolay V. Demin

V.A. Nasonova Research Institute of Rheumatology

Email: deminick@rambler.ru
ORCID iD: 0000-0003-0961-9785

Junior Researcher, Osteoporosis Laboratory

Russian Federation, Moscow

Natalia V. Toroptsova

V.A. Nasonova Research Institute of Rheumatology

Email: torop@irramn.ru
ORCID iD: 0000-0003-4739-4302

Dr Sci. (Med.), Head of Osteoporosis Laboratory

Russian Federation, Moscow

References

  1. Diaz B.B., Gonzalez D.A., Gannar F., et al. Myokines, physical activity, insulin resistance and autoimmune diseases. Immunology Letters. 2018;203:1–5. doi: 10.1016/j.imlet.2018.09.002.
  2. Ngeuleu A., Allali F., et al. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatology International, 2017;37(6):1015–1020. doi: 10.1007/s00296-017-3665-x.
  3. Mochizuki T., Yano K., Ikari K., Okazaki K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatrics & Gerontology International. 2019;19(9):907–912. doi: 10.1111/ggi.13747.
  4. Malmstrom T.K., Miller D.K., Simonsick E.M., et al. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28-36. doi: 10.1002/jcsm.12048.
  5. Cruz-Jentoft A.J., Bahat G., Bauer J., et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi: 10.1093/ageing/afy169.
  6. Торопцова Н.В., Добровольская О.В., Ефремова А.О., Никитинская О.А. Диагностическая значимость опросника SARC-F и тестов оценки мышечной силы для выявления саркопении у больных ревматоидным артритом. Научно-практическая ревматология. 2020;58(6):678–682. doi: 10.47360/1995-4484-2020-678-682 [Toroptsova N.V., Dobrovolskaya O.V., Efremova A.O., Nikitinskaya O.A. Diagnostic value of the SARC-f questionnaire and muscle strength tests for the detection of sarcopenia in patients with rheumatoid arthritis. Rheumatology Science and Practice. 2020;58(6):678–682. (In Russ.)]. doi: 10.47360/1995-4484-2020-678-682.
  7. Аудит состояния проблемы остеопороза 2020. URL: https://osteoporosis-russia.ru/wp-content/uploads/2022/02/audit_osteoporosis_raop.pdf (дата обращения 11.02.2025). [Audit of the state of the osteoporosis problem 2020. URL: https://osteoporosis-russia.ru/wp-content/uploads/2022/02/audit_osteoporosis_raop.pdf (accessed 11.02.2025). (In Russ.)].
  8. Kim M., Won C.W. Sarcopenia in Korean Community-Dwelling Adults Aged 70 Years and Older: Application of Screening and Diagnostic Tools From the Asian Working Group for Sarcopenia 2019 Update. J Am Med Dir Assoc. 2020;21(6):752–758. doi: 10.1016/j.jamda.2020.03.018.
  9. Santos L.P., Gonzalez M.C., Orlandi S.P., et al. New Prediction Equations to Estimate Appendicular Skeletal Muscle Mass Using Calf Circumference: Results From NHANES 1999-2006. JPEN J Parenter Enteral Nutr. 2019;43(8):998-1007. doi: 10.1002/jpen.1605
  10. Chen L.K., Woo J., Assantachai P., et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi: 10.1016/j.jamda.2019.12.012.
  11. Youden W.J. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35. doi: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3.
  12. Tresignie J., Scafoglieri A., Pieter Clarys J,. Cattrysse E. Reliability of standard circumferences in domain-related constitutional applications. Am J Hum Biol. 2013;25(5):637–642. doi: 10.1002/ajhb.22423.
  13. Kim S., Kim M., Lee Y., et al.. Calf Circumference as a Simple Screening Marker for Diagnosing Sarcopenia in Older Korean Adults: the Korean Frailty and Aging Cohort Study (KFACS). J Korean Med Sci. 2018;33(20):e151. doi: 10.3346/jkms.2018.33.e151.
  14. Rolland Y., Lauwers-Cances V., Cournot M., et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003;51(8):1120–1124. doi: 10.1046/j.1532-5415.2003.51362.x.
  15. Ukegbu P.O., Kruger H.S., Meyer J.D., et al. The association between calf circumference and appendicular skeletal muscle mass index of black urban women in Tlokwe City. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2018;23(3):86–90 doi: 10.1080/16089677.2018.1518825.
  16. Kawakami R., Miyachi M., Sawada S.S., et al. Cut-offs for calf circumference as a screening tool for low muscle mass: WASEDA’S Health Study. Geriatr Gerontol Int. 2020;20(10):943–950. doi: 10.1111/ggi.14025.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure 1. Calf circumference measuremen

Download (38KB)
3. Figure. 2. Association of appendicular muscle index and calf circumference

Download (66KB)
4. Figure 3. ROC curve for screening low muscle mass based on calf circumference

Download (58KB)

Copyright (c) 2025 Bionika Media